Automated, Closed, Integrated, Process Development (PD) And Manufacturing For T-Cells And Natural Killer (NK) Cells (E.G. CAR-T, CAR-NK)
Source: OmniaBio
CCRM has deep experience in optimizing and developing processes for various cell types to ensure success during cGMP manufacturing. One example is the CAR-T process developed for a key international client, which is now being used to treat patients in clinical trials and with initial positive outcomes.
- CCRM has developed next-generation CAR-T processes (e.g. serum-free, automated, closed); collaboration with Cytiva (formerly GE Life Sciences) allows us to leverage FlexFactory offering to enable expansion of client-site capacity
- CCRM has rapidly generated data to support IND filings under accelerated timelines
This website uses cookies to ensure you get the best experience on our website. Learn more